LIVE MARKET TRACKER :   BSE SENSEX   33053.04      |    NSE NIFTY 10192.95    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Top News  :  Lupin, Coromandel International and AstraZeneca to see some action today

Lupin, Coromandel International and AstraZeneca to see some action today (24-Jul-2017)

US Food and Drug Administration (USFDA) has successfully completed Prior Approval Inspection (PAI) at Lupin's Goa manufacturing facility without any observations. The inspection which started on July 17 concluded on July 21, 2017. Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Coromandel International has received environmental clearance for raising production capacity of its facility at Vishakhapatnam in Andhra Pradesh. The environment clearance to Rs 225-crore expansion project is subject to the compliance of specific and general conditions. The company's proposal is to raise phosphoric acid production capacity from 700 tonnes per day to 1,000 tonnes per day and other auxiliary facilities at Sriharipuram to achieve daily complex fertiliser production of 3,900 tonnes.

AstraZeneca Pharma India will be launching Osimertinib 40 mg and 80 mg (Tagrisso) in India on July 27, 2017. Osimertinib 40 mg and 80 mg (Tagrisso) is an oral anti-cancer drug for management of lung cancer. It is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an appropriate test, whose disease has progressed on or after EGFR TKI therapy. Osimertinib (Tagrisso) is the product of AstraZeneca group and has been approved in over 45 countries, including US, EU, Japan, China and other Asian countries.

Persistent Systems' wholly owned subsidiary in Germany namely, Persistent Systems Germany GmbH has entered into an agreement with PARX Werk AG, Switzerland (PARX) on July 21, 2017 to acquire PARX, a Salesforce Certified Platinum Partner in DACH region. The acquisition is subject to customary closing conditions which are expected to get completed within 3-4 weeks. The consideration would be in cash. The proposed acquisition strengthens Persistent's Salesforce practice through entry into new markets as well as provides new capabilities to support customers on their digital transformation initiatives.  

Vikas WSP has received export orders for an aggregate amount of Rs 119 crore for shipment of its newly developed guar gum product 'Thermo Guar-30' in the next two quarters. The company has already filed patent for the said product. Vikas WSP is one of India's foremost guar gum powder (GGP) manufacturer, supplying to all sectors of the food industry with an extensive range of quality products.

Speciality Restaurants has opened a new POH (Progressive Oriental House) restaurant at Mumbai. As continuation of the company's determination to dominate in Chinese and Pan Asian Market in India, the company has given birth to a new boutique oriental restaurant called Progressive Oriental House. This restaurant at Kamala Mills, Mumbai is targeted towards creme de la creme and HNI's, who are looking for newer flavours and experience.



Top News Today
Talwalkars commences construction of first leisure club in Pune
(13-Dec-2017)

Talwalkars commences construction of first leisure club in PuneTalwalkars Better Value Fitness has commenced the construction of its first leisure club in Wakad, Pune. Post the compliance of various statutory procedures, the club project has received necessary sanctions......click on news to read complete article.

NIIT features in '2017 Top 20 IT Training Company' list
(13-Dec-2017)

NIIT features in NIIT has been featured by Training Industry among 2017 Top 20 IT Training Company for the eighth consecutive year. Training Industry is one of the most trusted sources of information on the business of......click on news to read complete article.

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating Tablets
(13-Dec-2017)

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating TabletsOrchid Pharma has received ANDA approval from USFDA for Aripiprazole Orally-Disintegrating Tablets USP, 10 mg and 15 mg. Aripiprazole Orally-Disintegrating Tablets are atypical antipsychotic, indicated......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Top News News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.